Pharmaceuticals & Diagnostics

  • Adenovir Pharma

    Adenovir Pharma is a Swedish based development company developing new solutions for treatment of certain infectious diseases affecting the eyes. Adenovir Pharma was founded by researchers at the department of Virology, Umeå University, Sweden and the P.U.L.S. AB network.

    Read more

  • APL

    Manufacturing of Pharmaceutical Products according to EU GMP rules, approved by the Swedish Medical Products Agency.

    Read more

  • Betagenon AB

    The goal of Betagenon is to become one of the leaders in the discovery and early stage development of novel, safe and effective drug therapies for treatment of Type II Diabetes.

    Read more

  • Creative Antibiotics (former Innate Pharmaceuticals)

    A drug discovery company that develops virulence blocking agents, a novel class of anti-infectives that may complement or replace antibiotics. The risk of bacteria developing a resistance to virulence blockers is probably low. The vision is to increase the global health by minimizing the problem with resistant bacteria.

    Read more

  • Helicure

    Helicure develops vaccines to cure peptic ulcer disease and to protect against gastric cancer, based on eradication of "bad" Helicobacter pylori infections.

    Read more

  • Nordic Biomarker

    Nordic Biomarker has a strong position as a creator of innovative immunoassays. We have all the tools at our disposal for the development of novel antibodies. We have a highly trained staff, with many years of experience in research and development. We hold a particularly strong position in the field of particle-enhanced immunoassays, where we have delivered solutions to several OEM-customers.

    Read more

  • Omnio AB

    Development of health care products and contract research in the field of molecular biology and protein chemistry.

    Read more

  • Omnio Healer

    Omnio Healer develops products for the treatment of various types of wounds, and also for treating different types of infections. These products may contain plasminogen or other substances with similar effects.

    Read more

  • Strålen AB

    Strålen is a privately owned research and development company based in Umeå. We work in close collaboration with medical research and clinical doctors at the University hospital in Umeå.

    Read more

  • Swedish Orphan Biovitrum

    Swedish Orphan Biovitrum’s business concept is to develop and supply orphan drugs – drugs designated for the treatment of rare, life-threatening or chronically debilitating diseases.

    Read more

  • UmanDiagnostics AB

    Is presently involved in establishing a new diagnostic immunochemical test for detection of degenerative diseases of the brain - NFL light.

    Read more

  • Umecrine AB

    Umecrine AB develops medications against CNS-related conditions caused by adversive sex and stress hormones. Drugs that block the adversive effects are in pre-clinical testing.

    Read more

  • Umecrine Cognition

    Umecrine Cognition AB was founded as a subsidiary to Umecrine AB. The company is active in research and development within the field of GABA steroids and inhibitors of such steroids within the indication area of Alzheimer´s disease. The company develops pharmaceutical agents against negative mental and neurological symptoms caused by endogenous CNS-active stress- and sex steroids. The portfolio of the company includes a number of newly discovered lead compounds that are under investigation.

    Read more

  • Umecrine Mood

    Umecrine Mood AB was founded in 2006 as a subsidiary to Umecrine AB. The business concept of the company is to develop treatments for the negative mental and physical symptoms in Premenstrual Dysphoric Disorder (PMDD) and Premenstrual Syndrome (PMS) caused by endogenous CNS-active steroids derived from the corpus luteum of the ovary. The company offers a unique and novel treatment principle based on inhibition of GABA-steroid action. The portfolio of the company includes a number of newly discovered lead compounds and a drug candidate that is under clinical investigation.

    Read more